- Home
- ZYXI vs RNXT Comparison
ZYXI vs RNXT Comparison
Compare ZYXI & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- RNXT
- Stock Information
- Founded
- ZYXI 1996
- RNXT 2012
- Country
- ZYXI United States
- RNXT United States
- Employees
- ZYXI N/A
- RNXT N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- RNXT Health Care
- Exchange
- ZYXI Nasdaq
- RNXT Nasdaq
- Market Cap
- ZYXI 35.8M
- RNXT 35.2M
- IPO Year
- ZYXI N/A
- RNXT 2021
- Fundamental
- Price
- ZYXI $0.62
- RNXT $0.81
- Analyst Decision
- ZYXI Hold
- RNXT Strong Buy
- Analyst Count
- ZYXI 3
- RNXT 2
- Target Price
- ZYXI $3.00
- RNXT $7.50
- AVG Volume (30 Days)
- ZYXI 6.0M
- RNXT 396.4K
- Earning Date
- ZYXI 11-17-2025
- RNXT 11-13-2025
- Dividend Yield
- ZYXI N/A
- RNXT N/A
- EPS Growth
- ZYXI N/A
- RNXT N/A
- EPS
- ZYXI N/A
- RNXT N/A
- Revenue
- ZYXI $108,202,000.00
- RNXT $928,000.00
- Revenue This Year
- ZYXI N/A
- RNXT $2,895.35
- Revenue Next Year
- ZYXI $7.07
- RNXT $313.04
- P/E Ratio
- ZYXI N/A
- RNXT N/A
- Revenue Growth
- ZYXI N/A
- RNXT N/A
- 52 Week Low
- ZYXI $0.38
- RNXT $0.70
- 52 Week High
- ZYXI $8.72
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- ZYXI 33.14
- RNXT 37.36
- Support Level
- ZYXI $0.38
- RNXT $0.73
- Resistance Level
- ZYXI $0.74
- RNXT $0.87
- Average True Range (ATR)
- ZYXI 0.15
- RNXT 0.08
- MACD
- ZYXI -0.05
- RNXT -0.02
- Stochastic Oscillator
- ZYXI 28.94
- RNXT 22.92
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.